Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Roussel
Pcn181 - Cost-Utility Analysis of Adjuvant Pertuzumab-Based Regimen in Women With Her2-Positive Breast Cancer in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcn74 - A Budget-Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early Her2-Positive Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility Analysis of Adjuvant Trastuzumab Therapy for HER2-positive Early-Stage Breast Cancer in the Philippines
BMC Health Services Research
Health Policy
Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility Analysis of Adjuvant Therapies for Breast Cancer in Iran
International Journal of Technology Assessment in Health Care
Health Policy
Safety Assessment of Neoadjuvant Pertuzumab Combined With Trastuzumab in Nonmetastatic HER2-Positive Breast Cancer in Postmenopausal Elderly Women of South Asia
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
Oncofertility Counselling in Premenopausal Women With HER2-positive Breast Cancer
Oncotarget
Oncology
Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib
AboutOpen
Neratinib in Adjuvant Treatment of Patients With HER2-positive Breast Cancer — Less Is More?
Oncology in Clinical Practice
Oncology
